Beobachtungsplan, NIS 385: A Multinational, Single Arm, Observational Study to Evaluate the Real-world Effectiveness and Pattern of Use of Mepolizumab in Patients with Severe Eosinophilic Asthma (204710).

Datei

• Artikel "Beobachtungsplan, NIS 385: A Multinational, Single Arm, Observational Study to Evaluate the Real-world Effectiveness and Pattern of Use of Mepolizumab in Patients with Severe Eosinophilic Asthma (204710)."Herunterladen(PDF, 549KB, Datei ist nicht barrierefrei)